Emyria Ltd ( (AU:EMD) ) has shared an announcement.
Emyria Limited has opened its second Empax Centre within Perth Clinic, a leading private mental health hospital in Western Australia, expanding its treatment capacity by 50%. This move is part of a broader strategy to meet growing national demand and align with healthcare funders’ requirements for evidence-based mental health therapies. The new centre will initially treat patients with PTSD and treatment-resistant depression, with plans for further expansion on the East Coast. The initiative reflects Emyria’s commitment to scalable, evidence-based care and its potential for lasting patient impact, supported by private insurers and major payers.
More about Emyria Ltd
Emyria Limited specializes in the development and delivery of innovative treatments for mental health and select neurological conditions.
YTD Price Performance: -14.71%
Average Trading Volume: 197,544
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$14.25M
Learn more about EMD stock on TipRanks’ Stock Analysis page.